Evoking potent RNAi response in cancer using novel 2’-OMe-phosphorodithioated modified siRNAs. Homo sapiens
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Use of MePS2-modified siRNAs to target GRAM Domain Containing 1B (GRAMD1B), a novel protein in taxane resistance. Overall design: Two groups of samples are included: 1. siControl treated HeyA8-MDR and 2. siGRAMD1B treated HeyA8-MDR. Gene expression profiles of siGRAMD1B-HeyA8-MDR cells were compared to that of siControl-HeyA8MDR cells.
创建时间：
2014-01-28
